Integer Holdings Corporation (NYSE:ITGR) Given Consensus Rating of “Moderate Buy” by Brokerages

Shares of Integer Holdings Corporation (NYSE:ITGR) have been assigned a consensus recommendation of “Moderate Buy” from the thirteen research firms that are covering the stock, Marketbeat.com reports. Seven analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company. The average 12-month price target among analysts that have covered the stock in the last year is $97.00.

ITGR has been the subject of a number of analyst reports. Truist Financial upped their price objective on shares of Integer from $97.00 to $110.00 and gave the company a “buy” rating in a report on Thursday, July 16th. HC Wainwright reiterated a “buy” rating on shares of Integer in a report on Friday, July 24th. Citigroup increased their price target on shares of Integer from $92.00 to $96.00 and gave the company a “neutral” rating in a research note on Wednesday, July 8th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Integer in a research note on Thursday, June 18th. Finally, Freedom Capital upgraded Integer to a “strong-buy” rating in a report on Wednesday, July 22nd.

Integer Stock Up 20.0%

ITGR stock opened at $121.07 on Friday. The stock has a market capitalization of $4.11 billion, a P/E ratio of 30.19, a P/E/G ratio of 2.40 and a beta of 0.64. The firm has a 50-day simple moving average of $93.88 and a 200-day simple moving average of $88.95. The company has a quick ratio of 2.38, a current ratio of 3.75 and a debt-to-equity ratio of 0.77. Integer has a 52 week low of $62.00 and a 52 week high of $123.50.

Integer (NYSE:ITGR) last posted its quarterly earnings data on Thursday, April 30th. The medical equipment provider reported $1.20 EPS for the quarter, missing the consensus estimate of $1.21 by ($0.01). Integer had a net margin of 7.64% and a return on equity of 12.83%. The firm had revenue of $439.58 million during the quarter, compared to analyst estimates of $426.48 million. During the same period in the prior year, the company posted $1.31 earnings per share. The firm’s revenue for the quarter was up .5% compared to the same quarter last year. Equities analysts forecast that Integer will post 6.04 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of the stock. EverSource Wealth Advisors LLC boosted its position in shares of Integer by 48.1% during the 1st quarter. EverSource Wealth Advisors LLC now owns 360 shares of the medical equipment provider’s stock worth $32,000 after purchasing an additional 117 shares during the period. Salomon & Ludwin LLC boosted its position in shares of Integer by 46.8% during the fourth quarter. Salomon & Ludwin LLC now owns 370 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 118 shares during the period. Kestra Advisory Services LLC boosted its position in shares of Integer by 0.6% during the fourth quarter. Kestra Advisory Services LLC now owns 21,424 shares of the medical equipment provider’s stock worth $1,680,000 after buying an additional 136 shares during the period. Orion Porfolio Solutions LLC lifted its stake in Integer by 1.4% during the 2nd quarter. Orion Porfolio Solutions LLC now owns 9,755 shares of the medical equipment provider’s stock worth $1,200,000 after acquiring an additional 138 shares in the last quarter. Finally, Lido Advisors LLC lifted its stake in Integer by 5.5% during the 4th quarter. Lido Advisors LLC now owns 2,887 shares of the medical equipment provider’s stock worth $226,000 after acquiring an additional 151 shares in the last quarter. Institutional investors and hedge funds own 99.29% of the company’s stock.

Integer Company Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.